Editorial: Merck publishes a fake journal
The spectre of Vioxx, the blockbuster non-steroidal anti inflammatory drug (NSAID), continues to haunt pharmaceutical giant Merck even five years after the drug was withdrawn from the market due to…
Category: Vioxx
Vioxx: drug promotion in guise of research
Published in The Hindu on October 16, 2008 Phase IV trials for postmarketing surveillance of drugs are common and are permitted by the regulators. But it is a different matter…
Vioxx safety data manipulated
Published in The Hindu on April 24, 2008 The ghost of Vioxx is coming to haunt the pharmaceutical company Merck four years after it withdrew the drug from the market.…
Science Chronicle 